In-vitro tipranavir susceptibility of HIV-1 isolates with reduced susceptibility to other protease inhibitors

被引：48

作者：

Back, NKT ^{[1
]}

van Wijk, A ^{[1
]}

Remmerswaal, D ^{[1
]}

van Monfort, M ^{[1
]}

Nijhuis, M ^{[1
]}

Schuurman, R ^{[1
]}

Boucher, CAB ^{[1
]}

机构：

[1] Univ Utrecht Hosp, Eijkman Winkler Inst, Dept Virol, Utrecht, Netherlands

来源：

AIDS | 2000年 / 14卷 / 01期

关键词：

D O I：

10.1097/00002030-200001070-00019

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：101 / 102

页数：2

共 12 条

[1]

BACK NKT, 1999, ANTIVIRAL THER S1, V4, P11

[2] RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].

BOOM, R ;

SOL, CJA ;

SALIMANS, MMM ;

JANSEN, CL ;

WERTHEIMVANDILLEN, PME ;

VANDERNOORDAA, J .

JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503

[3] Human immunodeficiency virus type 1 drug susceptibility determination by using recombinant viruses generated from patient sera tested in a cell-killing assay [J].

Boucher, CAB ;

Keulen, W ;

vanBommel, T ;

Nijhuis, M ;

DeJong, D ;

DeJong, MD ;

Schipper, P ;

Back, NKT .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2404-2409

[4] In vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolates [J].

Chong, KT ;

Pagano, PJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2367-2373

[5]

LARDER B, 1999, ANTIVIR THER S, V4, P5

[6] ANALYSIS OF RESISTANCE TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE INHIBITORS BY USING MATCHED BACTERIAL EXPRESSION AND PROVIRAL INFECTION VECTORS [J].

MASCHERA, B ;

FURFINE, E ;

BLAIR, ED .

JOURNAL OF VIROLOGY, 1995, 69 (09) :5431-5436

[7] Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy [J].

Nijhuis, M ;

Boucher, CAB ;

Schipper, P ;

Leitner, T ;

Schuurman, R ;

Albert, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (24) :14441-14446

[8]

NIJHUIS M, 1995, BIOTECHNIQUES, V19, P178

[9] Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor [J].

Poppe, SM ;

Slade, DE ;

Chong, KT ;

Hinshaw, RR ;

Pagano, PJ ;

Markowitz, M ;

Ho, DD ;

Mo, H ;

Gorman, RR ;

Dueweke, TJ ;

Thaisrivongs, S ;

Tarpley, WG .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1058-1063

[10]

REED L. J., 1938, AMER JOUR HYG, V27, P493

← 1 2 →